TAK

#465
Takeda Pharmaceutical Company Limited American Depositary Share
15.9 7 USD
+9782.43%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
15.95
15.98
Range Annuel
0.16
18.89
Changement quotidien
+9782.43%
Changement Mensuel
-4.37%
Evolution sur 6 mois
+10.06%
Changement Annuel
+12.58%
Clôture Précédente
0.1 6
Open
15.9 7
Low
15.9 5
High
15.9 8
Volume
809
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 20202021202220232024 TTM

Takeda Pharmaceutical Company Limited American Depositary Share

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.

Nouvelles